These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 24210635)

  • 1. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
    van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M
    Maturitas; 2014 Feb; 77(2):137-41. PubMed ID: 24210635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease.
    Mayer O; Seidlerová J; Bruthans J; Filipovský J; Timoracká K; Vaněk J; Cerná L; Wohlfahrt P; Cífková R; Theuwissen E; Vermeer C
    Atherosclerosis; 2014 Jul; 235(1):162-8. PubMed ID: 24835435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients.
    Dahlberg S; Ede J; Schurgers L; Vermeer C; Kander T; Klarin B; Schött U
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K status and mortality after kidney transplantation: a cohort study.
    Keyzer CA; Vermeer C; Joosten MM; Knapen MH; Drummen NE; Navis G; Bakker SJ; de Borst MH
    Am J Kidney Dis; 2015 Mar; 65(3):474-83. PubMed ID: 25453995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.
    Dalmeijer GW; van der Schouw YT; Vermeer C; Magdeleyns EJ; Schurgers LJ; Beulens JW
    J Nutr Biochem; 2013 Apr; 24(4):624-8. PubMed ID: 22819559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk.
    Jespersen T; Møllehave LT; Thuesen BH; Skaaby T; Rossing P; Toft U; Jørgensen NR; Corfixen BL; Jakobsen J; Frimodt-Møller M; Linneberg A
    Clin Biochem; 2020 Sep; 83():49-56. PubMed ID: 32422228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Vitamin K Is Inversely Associated with Incident Cardiovascular Disease Risk among Those Treated for Hypertension in the Health, Aging, and Body Composition Study (Health ABC).
    Shea MK; Booth SL; Weiner DE; Brinkley TE; Kanaya AM; Murphy RA; Simonsick EM; Wassel CL; Vermeer C; Kritchevsky SB;
    J Nutr; 2017 May; 147(5):888-895. PubMed ID: 28356433
    [No Abstract]   [Full Text] [Related]  

  • 8. The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.
    Mayer O; Seidlerová J; Vaněk J; Karnosová P; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Windrichová J; Knapen MH; Drummen NE; Vermeer C
    Int J Cardiol; 2016 Jan; 203():916-22. PubMed ID: 26618253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish population.
    Liu YP; Gu YM; Thijs L; Knapen MH; Salvi E; Citterio L; Petit T; Carpini SD; Zhang Z; Jacobs L; Jin Y; Barlassina C; Manunta P; Kuznetsova T; Verhamme P; Struijker-Boudier HA; Cusi D; Vermeer C; Staessen JA
    Hypertension; 2015 Feb; 65(2):463-70. PubMed ID: 25421980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
    Dalmeijer GW; van der Schouw YT; Magdeleyns EJ; Vermeer C; Verschuren WM; Boer JM; Beulens JW
    Diabetes Care; 2013 Nov; 36(11):3766-71. PubMed ID: 23877986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating desphospho-uncarboxylated matrix γ-carboxyglutamate protein and the risk of coronary heart disease and stroke.
    Dalmeijer GW; van der Schouw YT; Magdeleyns EJ; Vermeer C; Verschuren WM; Boer JM; Beulens JW
    J Thromb Haemost; 2014 Jul; 12(7):1028-34. PubMed ID: 24826813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix Gla Protein, Plaque Stability, and Cardiovascular Events in Patients with Severe Atherosclerotic Disease.
    Zwakenberg SR; van der Schouw YT; Vermeer C; Pasterkamp G; den Ruijter HM; Beulens JWJ
    Cardiology; 2018; 141(1):32-36. PubMed ID: 30304721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study.
    Pivin E; Ponte B; Pruijm M; Ackermann D; Guessous I; Ehret G; Liu YP; Drummen NE; Knapen MH; Pechere-Bertschi A; Paccaud F; Mohaupt M; Vermeer C; Staessen JA; Vogt B; Martin PY; Burnier M; Bochud M
    Hypertension; 2015 Jul; 66(1):85-92. PubMed ID: 25987667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K status and physical decline in older adults-The Longitudinal Aging Study Amsterdam.
    van Ballegooijen AJ; van Putten SR; Visser M; Beulens JW; Hoogendijk EO
    Maturitas; 2018 Jul; 113():73-79. PubMed ID: 29903651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
    Machado-Fragua MD; Hoogendijk EO; Struijk EA; Rodriguez-Artalejo F; Lopez-Garcia E; Beulens JW; van Ballegooijen AJ
    Eur J Nutr; 2020 Apr; 59(3):1243-1251. PubMed ID: 31069456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.
    Schlieper G; Westenfeld R; Krüger T; Cranenburg EC; Magdeleyns EJ; Brandenburg VM; Djuric Z; Damjanovic T; Ketteler M; Vermeer C; Dimkovic N; Floege J; Schurgers LJ
    J Am Soc Nephrol; 2011 Feb; 22(2):387-95. PubMed ID: 21289218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.
    Boxma PY; van den Berg E; Geleijnse JM; Laverman GD; Schurgers LJ; Vermeer C; Kema IP; Muskiet FA; Navis G; Bakker SJ; de Borst MH
    PLoS One; 2012; 7(10):e47991. PubMed ID: 23118917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
    Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
    Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease.
    Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
    Kidney Blood Press Res; 2016; 41(3):231-9. PubMed ID: 27100101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of nephrolithiasis is causally related to inactive matrix Gla protein, a marker of vitamin K status: a Mendelian randomization study in a Flemish population.
    Wei FF; Thijs L; Zhang ZY; Jacobs L; Yang WY; Salvi E; Citterio L; Cauwenberghs N; Kuznetsova T; E A Drummen N; Hara A; Manunta P; Li Y; Verhamme P; Allegaert K; Cusi D; Vermeer C; Staessen JA
    Nephrol Dial Transplant; 2018 Mar; 33(3):514-522. PubMed ID: 28340119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.